However, activation of the serine/threonine kinase enzyme AKT in human cholangiocarcinoma was associated with increased radioresistance, thus suggesting to us that decreasing AKT activation could reduce radioresistance and increase sensitivity to RT (35). The gene discussed is MARK2; the disease is cholangiocarcinoma.